Kraken exchange will begin trading the SFI token from Saffron on October 23. Saffron is a peer-to-peer protocol that adjusts risk by redistributing yields from decentralized finance activities based on user preferences. This listing allows Kraken users to trade Saffron's asset, expanding options in the DeFi market. The move highlights growing interest in risk-managed DeFi products.
The Kraken exchange's upcoming trading of Saffron's SFI token is noted here with Pluang's cryptocurrency market context as of Oct 24, 2026 00:22 WIB: Among 50 major cryptocurrencies on Pluang, 44 rose and 5 fell today. Notable movers include UNI (Uniswap) at Rp129.242 with a 3.05% increase and a typical hold time of 65 days, BNB (Binance Coin) at Rp13.493.881 with a 3.04% rise and a 90-day hold time, and YFI (Yearn) at Rp39.837.602 up 3.00% with a 94-day hold time.
Fortrea Holdings and Omico have formed a partnership to enhance precision oncology research in Australia by linking cancer patients to biomarker-matched clinical trials. This collaboration combines Fortrea's oncology trial expertise with Omico's Prec...
Fortrea Holdings Inc and Omico have formed a partnership to accelerate precision oncology research in Australia by connecting cancer patients to biomarker-driven clinical trials. The collaboration combines Fortrea's expertise in oncology clinical tri...
Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research in Australia by combining Fortrea's clinical trial expertise with Omico's Precision Oncology Screening Platform (PrOSPeCT). This collaboration aims to impr...
Fortrea Holdings Inc and Omico have formed a partnership to enhance precision oncology research in Australia by matching cancer patients with biomarker-driven clinical trials. This collaboration combines Fortrea's expertise in oncology clinical trial...
Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research by improving biomarker-based clinical trial planning and patient recruitment in Australia. The collaboration leverages Fortrea's clinical trial expertise a...
